Ordering Recommendation

Preferred initial panel for the evaluation of lung inflammation or injury in various types of interstitial lung disease (ILD).

Mnemonic
KL6_SPD
Methodology

Quantitative Enzyme-Linked Immunosorbent Assay/ Quantitative Immunoturbidimetric

Performed

Tue

Reported

1-8 days

New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
Collect

Plain Red.

Specimen Preparation

Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 3 mL serum to ARUP Standard Transport Tube. (Min: 1.5 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Plasma, CSF, or other body fluids. Contaminated, heat-inactivated, hemolyzed, icteric, or severely lipemic specimens.

Remarks
Stability

Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 month

Reference Interval
Test Number
Components
Reference Interval
3001969 Human Surfactant Protein D (SP-D) 1-300 ng/mL
3001866 Krebs von den Lungen-6 0-500 U/mL

Interpretive Data

Refer to report.

Compliance Statement D: For laboratory tests using a manufactured RUO kit. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note
Hotline History
N/A
CPT Codes

83520 x2

Components
Component Test Code* Component Chart Name LOINC
3001867 Krebs von den Lungen-6 93369-7
3001970 Human Surfactant Protein D 74541-4
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Lung Injury Panel
Interstitial Lung Disease (ILD) Biomarkers Panel